Close Menu

Faking the Golgi

Researchers led by Rensselaer Polytechnic Institute's Robert Linhardt developed a prototype of an artificial Golgi complex based on a digital microfluidic chip. The researchers then used the chip to modify heparan sulfate chains. "This represents the first enzymatic modification of an immobilized substrate in a digital microfluidic device and a critical first step in the creation of an artificial Golgi," the researchers write.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

NPR reports the US Food and Drug Administration has approved a treatment for a genetic disorder that causes rapid aging.

Late-stage testing indicates the AstraZeneca and Oxford University SARS-CoV-2 vaccine can have up to 90 percent efficacy, the Associated Press reports.

ScienceInsider reports Nature Communications is reviewing a paper on mentorship following social media criticism arguing it is sexist.

In PLOS this week: method to account for sequencing errors in phylogenies, study of influenza A in Switzerland, and more.